Abstract:The concept of "stemness" incorporates the molecular mechanisms that regulate the unlimited self-regenerative potential typical of undifferentiated primitive cells. These cells possess the unique ability to navigate the cell cycle, transitioning in and out of the quiescent G0 phase, and hold the capacity to generate diverse cell phenotypes. Stem cells, as undifferentiated precursors endow with extraordinary regenerative capabilities, exhibit a heterogeneous and tissue-specific distribution throughout the human body. The identification and characterization of distinct stem cell populations across various tissues have revolutionized our understanding of tissue homeostasis and regeneration. From the hematopoietic to the nervous and musculoskeletal systems, the presence of tissue-specific stem cells underlines the complex adaptability of multicellular organisms. Recent investigations have revealed a diverse cohort of non-hematopoietic stem cells (non-HSC), primarily within bone marrow and other stromal tissue, alongside established hematopoietic stem cells (HSC). Among these non-HSC, a rare subset exhibits pluripotent characteristics. In vitro and in vivo studies have demonstrated the remarkable differentiation potential of these putative stem cells, known by various names including multipotent adult progenitor cells (MAPC), marrow-isolated adult multilineage inducible cells (MIAMI), small blood stem cells (SBSC), very small embryonic-like stem cells (VSELs), and multilineage differentiating stress enduring cells (MUSE). The diverse nomenclatures assigned to these primitive stem cell populations may arise from different origins or varied experimental methodologies. This review aims to present a comprehensive comparison of various subpopulations of multipotent/pluripotent stem cells derived from stromal tissues. By analysing isolation techniques and surface marker expression associated with these populations, we aim to delineate the similarities and distinctions among stromal tissue-derived stem cells. Understanding the nuances of these tissue-specific stem cells is critical for unlocking their therapeutic potential and advancing regenerative medicine. The future of stem cells research should prioritize the standardization of methodologies and collaborative investigations in shared laboratory environments. This approach could mitigate variability in research outcomes and foster scientific partnerships to fully exploit the therapeutic potential of pluripotent stem cells.

What problem does this paper attempt to address?

The problem that this paper attempts to solve is related to the diversity and therapeutic applications of pluripotent/totipotent stem cell populations in mesenchymal tissues and peripheral blood. Specifically, the authors hope to compare and understand the similarities and differences between pluripotent/totipotent stem cells from different sources by analyzing the isolation methods of these stem cell populations and the expression of surface markers. This helps to determine whether the same core stem cell population can be isolated by different methods and to understand how the biological characteristics of these cells change under different experimental conditions. The main objectives of the paper can be summarized as follows: 1. **Provide comprehensive reports and comparisons**: Provide comprehensive reports and comparisons of various pluripotent/totipotent stem cell sub - populations isolated from mesenchymal tissues. 2. **Analyze isolation techniques and surface markers**: Identify their commonalities and differences by analyzing the isolation techniques and surface marker expression of these stem cells. 3. **Explore naming diversity**: Explain why these stem cell populations have different names (such as MAPC, MIAMI, SBSC, VSEL and MUSE), and whether these naming differences reflect different origins or experimental methods. 4. **Promote the development of regenerative medicine**: Provide theoretical basis and technical support for the therapeutic applications of regenerative medicine by understanding the characteristics and functions of these stem cells. 5. **Standardize research methods**: Emphasize that future research should give priority to the standardization of methods and cooperation between laboratories in order to reduce the variability of research results, promote scientific cooperation, and fully explore the therapeutic potential of totipotent stem cells. In summary, this review aims to provide a deeper understanding and guidance for research and applications in the field of regenerative medicine by systematically analyzing and comparing different types of pluripotent/totipotent stem cells.

Multipotent/pluripotent stem cell populations in stromal tissues and peripheral blood: exploring diversity, potential, and therapeutic applications

Mesenchymal Stem Cell Subpopulations: Phenotype, Property and Therapeutic Potential.

Adipogenic Placenta-Derived Mesenchymal Stem Cells Are Not Lineage Restricted by Withdrawing Extrinsic Factors: Developing a Novel Visual Angle in Stem Cell Biology

Recent advances in tissue stem cells

Combined Single-Cell Functional and Gene Expression Analysis Resolves Heterogeneity within Stem Cell Populations

Specific Blood Cells Derived From Pluripotent Stem Cells: An Emerging Field With Great Potential In Clinical Cell Therapy

Functional Heterogeneity of Bone Marrow Mesenchymal Stem Cell Subpopulations in Physiology and Pathology

Mesenchymal stem cells of different origin: Comparative evaluation of proliferative capacity, telomere length and pluripotency marker expression

Concise Review: Mesenchymal Stem Cells Derived from Human Pluripotent Cells, an Unlimited and Quality-Controllable Source for Therapeutic Applications

Evaluating Strategies to Assess the Differentiation Potential of Human Pluripotent Stem Cells: A Review, Analysis and Call for Innovation

Clinical implications of differential functional capacity between tissue-specific human mesenchymal stromal/stem cells

Single-cell Transcriptomic Analysis Reveals the Cellular Heterogeneity of Mesenchymal Stem Cells

Mesenchymal Stem Cell Preparations—Comparing Apples and Oranges

Stemness-related genes revealed by single-cell profiling of naive and stimulated human CD34<SUP>+</SUP> cells from CB and mPB

Progress in Multilineage Potential Study of Bone Marrow Stromal Stem Cell

Differentiation Of Embryonic Stem Cells To Vascular Cell Lineages

Comparison of molecular profiles of human mesenchymal stem cells derived from bone marrow, umbilical cord blood, placenta and adipose tissue

Stem Cells and Regenerative Medicine: Myth or Reality of the 21th Century

Research status of pluripotent stem cells from different origins

Mesenchymal stromal cells (MSCs): science and f(r)iction

Stem cell heterogeneity, plasticity, and regulation